Journey Medical
DERM
33 hedge funds and large institutions have $6.68M invested in Journey Medical in 2024 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 12 closing their positions.
71% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 7
2.91% more ownership
Funds ownership: 11.62% → 14.52% (+2.9%)
8% less funds holding
Funds holding: 36 → 33 (-3)
23% less capital invested
Capital invested by funds: $8.63M → $6.68M (-$1.95M)
25% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$846K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$787K |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
+$603K |
| 4 |
Walleye Capital
New York
|
+$488K |
| 5 |
HBCM
Heron Bay Capital Management
Bloomfield Hills,
Michigan
|
+$147K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$637K |
| 2 |
Neuberger Berman Group
New York
|
-$468K |
| 3 |
RAG
RIA Advisory Group
Des Moines,
Iowa
|
-$277K |
| 4 |
Millennium Management
New York
|
-$169K |
| 5 |
Jane Street
New York
|
-$160K |
DERM Hedge Fund Activity: Q1 2024 in Review
33 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Journey Medical (DERM) for Q1 2024, worth a combined $6.68M — down 23% from $8.63M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of DERM and 9 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 12 added.
The largest buyer was Acadian Asset Management, adding an estimated $846K. The largest seller was EAM Investors, exiting entirely with an estimated $637K sold.
- 33 institutional investors held Journey Medical (DERM) as of Q1 2024, down from 36 in Q4 2023.
- Funds reported $6.68M of Journey Medical stock for Q1 2024, down 23% quarter-over-quarter.
- 9 funds opened new Journey Medical positions in Q1 2024 and 12 closed out, a net change of -3 holders.
- The largest Journey Medical buyer in Q1 2024 was Acadian Asset Management, an estimated $846K added.
- The largest Journey Medical seller in Q1 2024 was EAM Investors, an estimated $637K sold.
Based on aggregated 13F filings for Q1 2024.